Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 0 | 0 | 0 | 1,436 | 1,697 |
| Gross Profit | N/A | N/A | N/A | 1,436 | 1,697 |
| Operating Expenses | 61,138 | 45,237 | 19,584 | 9,348 | 9,502 |
| Operating Income | -61,138 | -45,237 | -19,584 | -7,912 | -7,805 |
| Interest Expense | 581 | 0 | 0 | 0 | 0 |
| Other Income | 9,348 | 2,381 | -81,022 | 587 | -102 |
| Pre-tax Income | -52,371 | -42,856 | -100,606 | -7,325 | -7,907 |
| Net Income Continuous | -52,371 | -42,856 | -100,606 | -7,325 | -7,907 |
| Net Income | $-52,371 | $-42,856 | $-100,606 | $-7,325 | $-7,907 |
| EPS Basic Total Ops | -1.08 | -1.06 | -5.02 | -17.48 | -17.84 |
| EPS Basic Continuous Ops | -1.08 | -1.06 | -5.02 | -17.48 | -18.35 |
| EPS Diluted Total Ops | -1.08 | -1.06 | -5.02 | -17.48 | -17.84 |
| EPS Diluted Continuous Ops | -1.08 | -1.06 | -5.02 | -17.48 | -18.35 |
| EPS Diluted Before Non-Recurring Items | -1.08 | -1.06 | -2.13 | N/A | N/A |
| EBITDA(a) | $-64,075 | $-44,581 | $-19,425 | $-7,912 | $-7,805 |